BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9611684)

  • 1. Further investigations on the efficacy of a non-specific defence inducer evaluated in calves exposed to infectious bovine rhinotracheitis virus.
    Castrucci G; Frigeri F; Osburn BI; Ferrari M; Barreca F; Salvatori D
    Comp Immunol Microbiol Infect Dis; 1998 Apr; 21(2):155-63. PubMed ID: 9611684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of a non-specific defence mechanism inducer in calves exposed to bovine herpesvirus-1 infection: preliminary trials.
    Castrucci G; Ferrari M; Osburn BI; Frigeri F; Barreca F; Tagliati S; Cuteri V
    Comp Immunol Microbiol Infect Dis; 1995 Feb; 18(2):85-91. PubMed ID: 7621672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of immunomodulators in the control of infectious bovine rhinotracheitis.
    Castrucci G; Osburn BI; Frigeri F; Ferrari M; Salvatori D; Lo Dico M; Barreca F
    Comp Immunol Microbiol Infect Dis; 2000 Jul; 23(3):163-73. PubMed ID: 10855662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-specific defence inducer in preventing clinical signs of infectious bovine rhinotracheitis in calves.
    Castrucci G; Ferrari M; Osburn BI; Frigeri F; Barreca F; Tagliati S; Cuteri V
    Comp Immunol Microbiol Infect Dis; 1996 Jun; 19(3):163-9. PubMed ID: 8800541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of intranasal vaccination with a multivalent vaccine containing temperature-sensitive modified-live bovine herpesvirus type 1 for protection of seronegative and seropositive calves against respiratory disease.
    Mahan SM; Sobecki B; Johnson J; Oien NL; Meinert TR; Verhelle S; Mattern SJ; Bowersock TL; Leyh RD
    J Am Vet Med Assoc; 2016 Jun; 248(11):1280-6. PubMed ID: 27172345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a mutant bovine herpesvirus-1 (BHV-1) in post-arrival outbreaks of IBR in feedlot calves and protection with conventional vaccination.
    van Drunen Littel-van den Hurk S; Myers D; Doig PA; Karvonen B; Habermehl M; Babiuk LA; Jelinski M; Van Donkersgoed J; Schlesinger K; Rinehart C
    Can J Vet Res; 2001 Apr; 65(2):81-8. PubMed ID: 11346260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine recombinant interleukin-2 augments immunity and resistance to bovine herpesvirus infection.
    Reddy PG; Blecha F; Minocha HC; Anderson GA; Morrill JL; Fedorka-Cray PJ; Baker PE
    Vet Immunol Immunopathol; 1989 Nov; 23(1-2):61-74. PubMed ID: 2559538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effectiveness of the paramunity inducer Baypamun (PIND-ORF) for the prevention and metaphylaxis of an experimental infection with the infectious bovine rhinotracheitis virus in cattle].
    Strube W; Kretzdorn D; Grunmach J; Bergle RD; Thein P
    Tierarztl Prax; 1989; 17(3):267-72. PubMed ID: 2479119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of experimental subunit vaccines for infectious bovine rhinotracheitis.
    Lupton HW; Reed DE
    Am J Vet Res; 1980 Mar; 41(3):383-90. PubMed ID: 6245609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of human leukocyte A interferon on prevention of infectious bovine rhinotracheitis virus infection of cattle.
    Roney CS; Rossi CR; Smith PC; Lauerman LC; Spano JS; Hanrahan LA; William JC
    Am J Vet Res; 1985 Jun; 46(6):1251-5. PubMed ID: 2992320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of calves against bovine herpesvirus-1: assessment of the protective value of eight vaccines.
    Castrucci G; Frigeri F; Salvatori D; Ferrari M; Sardonini Q; Cassai E; Lo DM; Rotola A; Angelini R
    Comp Immunol Microbiol Infect Dis; 2002 Jan; 25(1):29-41. PubMed ID: 11831745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves.
    Xue W; Ellis J; Mattick D; Smith L; Brady R; Trigo E
    Vaccine; 2010 May; 28(22):3784-92. PubMed ID: 20381643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a combination viral vaccine for protection of cattle against experimental infection with field isolates of bovine herpesvirus-1.
    Ellis JA; Gow SP; Goji N; Jones C; Workman A; Henderson G; Rhodes C; Alaniz G; Meinert TR; Tucker CM
    J Am Vet Med Assoc; 2009 Sep; 235(5):563-72. PubMed ID: 19719449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies.
    Lemaire M; Schynts F; Meyer G; Georgin JP; Baranowski E; Gabriel A; Ros C; Belák S; Thiry E
    Vaccine; 2001 Sep; 19(32):4795-804. PubMed ID: 11535332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopotentiation of bovine respiratory disease virus vaccines by interleukin-1 beta and interleukin-2.
    Reddy DN; Reddy PG; Xue W; Minocha HC; Daley MJ; Blecha F
    Vet Immunol Immunopathol; 1993 Jun; 37(1):25-38. PubMed ID: 8393601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant effects of sulfolipo-cyclodextrin in a squalane-in-water and water-in-mineral oil emulsions for BHV-1 vaccines in cattle.
    Romera SA; Hilgers LA; Puntel M; Zamorano PI; Alcon VL; Dus Santos MJ; Blanco Viera J; Borca MV; Sadir AM
    Vaccine; 2000 Aug; 19(1):132-41. PubMed ID: 10924795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvanticity of recombinant bovine interleukin-1 beta: influence on immunity, infection, and latency in a bovine herpesvirus-1 infection.
    Reddy DN; Reddy PG; Minocha HC; Fenwick BW; Baker PE; Davis WC; Blecha F
    Lymphokine Res; 1990; 9(3):295-307. PubMed ID: 2169009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of active immunization with live bovine herpesvirus 1 vaccine by passive viral antibody.
    Patel JR; Shilleto RW
    Vaccine; 2005 Jul; 23(31):4023-8. PubMed ID: 15916839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ambient temperature on viral replication and serum antibody titers following administration of a commercial intranasal modified-live infectious bovine rhinotracheitis-parainfluenza-3 virus vaccine to beef cattle housed in high- and moderate-ambient temperature environments.
    Grissett GP; White BJ; Anderson DE; Larson RE; Miesner MD
    Am J Vet Res; 2014 Dec; 75(12):1076-82. PubMed ID: 25419807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of safety and efficacy of DNA vaccines against bovine herpesvirus-1 (BoHV-1) in calves.
    Petrini S; Ramadori G; Corradi A; Borghetti P; Lombardi G; Villa R; Bottarelli E; Guercio A; Amici A; Ferrari M
    Comp Immunol Microbiol Infect Dis; 2011 Jan; 34(1):3-10. PubMed ID: 19906427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.